Clinical and financial implications of 2 treatment strategies for donor-derived hepatitis C infections | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Clinical and financial implications of 2 treatment strategies for donor-derived hepatitis C infections

Stewart ZA, Stern J, NM A, et al. Clinical and financial implications of 2 treatment strategies for donor-derived hepatitis C infections. Transplant Direct [Internet]. 2021;7(10):e762. https://doi.org/10.1097/txd.0000000000001222

Publication Type:

Journal Article

Authors:

Stewart, ZA; Stern, J; Ali NM; et, al

Source:

Transplant Direct, Volume 7, Issue 10, p.e762 (2021)

URL:

https://doi.org/10.1097/txd.0000000000001222

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/34514117/

Export Citation:

RIS Format

Top